QuidelOrtho Corporation (QDEL)

QuidelOrtho Revenue

QuidelOrtho had revenue of $630.90M in the quarter ending June 28, 2026, with 2.77% growth. This brings the company's total for the last twelve months to $2.67B, down -2.46% year-over-year. In the year 2025, QuidelOrtho had annual revenue of $2.73B, down -1.89%. That makes QuidelOrtho the 4,118th largest company in the world by revenue and 1,122nd in the United States.

• Revenue (ttm): $2.67B
• Revenue Growth: -2.46%
• P/S Ratio: 0.35
• Revenue / Employee: $411,415
• Employees: 6,500
• Market Cap: 931.94M

Revenue Chart

Chart

Chart

Revenue by Segment

By Segment

Chart

• Labs 1.51B 55.1%
• Point of Care 601.60M 22.0%
• Immunohematology 543.80M 19.9%
• Donor Screening 52.60M 1.9%
• Molecular Diagnostics 26.50M 1.0%

By Geography

Chart

• North America 1.49B 54.5%
• EMEA 360.70M 13.2%
• China 334.70M 12.3%
• JPAC 293.00M 10.7%
• Latin America 252.90M 9.3%

Fiscal year ended Dec 31, 2025 See the full QuidelOrtho breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 28, 2025	2.73B	-52.70M	-1.89%
Dec 29, 2024	2.78B	-214.90M	-7.17%
Dec 31, 2023	3.00B	-268.20M	-8.21%
Jan 1, 2023	3.27B	1.57B	92.28%
Jan 2, 2022	1.70B	36.90M	2.22%
Jan 3, 2021	1.66B	-	-

Data Source: Fiscal.ai Last updated: Aug 6, 2026

Revenue data is provided by Fiscal.ai and updates within minutes after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 23, 2026

Data Sources Report a data error